YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells

In heterogeneous head and neck cancer (HNC), subtype-specific treatment regimens are currently missing. An integrated analysis of patient HNC subtypes using single-cell sequencing and proteome profiles reveals an epithelial-mesenchymal transition (EMT) signature within the epithelial cancer-cell population. The EMT signature coincides with PI3K/mTOR inactivation in the mesenchymal subtype. Conversely, the signature is suppressed in epithelial cells of the basal subtype which exhibits hyperactive PI3K/mTOR signalling. We further identify YBX1 phosphorylation, downstream of the PI3K/mTOR pathway, restraining basal-like cancer cell proliferation. In contrast, YBX1 acts as a safeguard against the proliferation-to-invasion switch in mesenchymal-like epithelial cancer cells, and its loss accentuates partial-EMT and in vivo invasion. Interestingly, phospho-YBX1 that is mutually exclusive to partial-EMT, emerges as a prognostic marker for overall patient outcomes. These findings create a unique opportunity to sensitise mesenchymal cancer cells to PI3K/mTOR inhibitors by shifting them towards a basal-like subtype as a promising therapeutic approach against HNC.

For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.

n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection No software was used for data collection.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Portfolio guidelines for submitting code & software for further information.

March 2021
Data Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A description of any restrictions on data availability -For clinical datasets or third party data, please ensure that the statement adheres to our policy The data that support this study are available in this paper and stored in GEO database as SuperSeries GSE226357 ( Note that full information on the approval of the study protocol must also be provided in the manuscript.

Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
The analysis was performed on available head and neck cancer samples with genetic, transcriptomic and proteomic profiles from TCGA and all tumour samples that passed quality control from GSE140042, GSE103322, GSE16490 for single-cell RNA sequencing. A minimum sample size of 3 replicates was considered as sufficient for RNA-seq and 2 replicates for RPPA analyses in cell lines and 3 replicates for RPPA analysis of mouse tissues. The replicate number was satisfactory to achieve a power between 0.8 and 1 as described in Ching, et. al, Power analysis and sample size estimation for RNA-seq differential expression. RNA, 2014.
Data exclusions For single-cell RNA sequencing, only samples with 2,000 to 4,000 sequenced cells were considered for downstream analyses while others were excluded. Cells with more than 200 RNA features were retained and others removed. RNA features detected in more than 2 cells were kept.

Replication
Independent in vitro experiments (e.g. colony formation and invasion assays, immunofluorescence) were repeated a minimum of three times, analyzed and confirmed by independent researchers. In vivo experiments (e.g. growth of xenografts) were independently repeated twice for each cell line. RNA-sequencing (3 replicates per cell line); RPPA (2 replicates per human cell line and 3 replicates per mouse tissue). The replicates are all reproducible.
Randomization No randomization was used in this study due to the small sample size. Covariates were controlled by running controls in parallel whenever applicable. Appropriate controls were used throughout the study.

Blinding
Blinding was not relevant for the bioinformatics analyses because our aims were based on objective computation results rather than human labels. Blinding for in vitro experiments was impractical. Blinding the in vivo experiments was not feasible given the study design, the ethical monitoring and labeling requirements of the animal facility.

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.

Reporting on sex
Both female and male mice were used in this study. Sex-based analysis was not conducted.
Field-collected samples This study did not involve samples collected from the field.

Ethics oversight
All animal studies including breeding, experiments and euthanasia protocols were performed in accordance with the National Code of Practice for the Care and Use of Animals for Scientific Purposes and the Animal Ethics guidelines, and were approved by the institutional Animal Experimentation Ethics Committee (E587 and E632) at the Peter MacCallum Cancer Center.
Note that full information on the approval of the study protocol must also be provided in the manuscript.

Flow Cytometry
Plots Confirm that: The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots. Gating strategy Cells were intitially gates based on FSC-A vs SSC-A, followed by FSC-A vs FSC-H to obtain single cells. Dead cells were excluded based on DAPI fluoresence. Where appropriate, cells with higher APC intensity compared to control cells were considered as the positive ones.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.